Our report on Ceapro Inc. is updated and continues to be rated Speculative Buy. Earnings are down in the first half of 2021 but this is due to increased spending on its Phase 1 (safety) trial of its Beta Glucan pills. The company is generating ample ...
Members only content
The content on this page is for members only. If you are a member, log in below. If you are not a member, please Register.